(redirected from M-CSF)
Also found in: Dictionary, Thesaurus, Medical, Financial, Acronyms, Encyclopedia.


An event, circumstance, influence, or element that plays a part in bringing about a result.

A factor in a case contributes to its causation or outcome. In the area of Negligence law, the factors, or chain of causation, are important in determining whether liability ensues from a particular action done by the defendant.

West's Encyclopedia of American Law, edition 2. Copyright 2008 The Gale Group, Inc. All rights reserved.


n. 1) a salesman who sells in his/her own name on behalf of others, taking a commission for services. 2) something that contributes to the result.

Copyright © 1981-2005 by Gerald N. Hill and Kathleen T. Hill. All Right reserved.


1 a mercantile agent. An agent who is in the ordinary course of business entrusted with goods or documents of title representing goods with a view to their sale. A factor has a lien over goods entrusted to him; this lien covers any claims he may have against his principal arising out of the agency. Most factors will be mercantile agents (and have the powers of such) for the purposes of the Factors Act 1889. Under this Act, in certain circumstances a factor may pass a good title to goods entrusted to him.
2 an institution to whom a company assigns its book debts (see FACTORING).
3 in Scotland a landlord or superior's agent.
Collins Dictionary of Law © W.J. Stewart, 2006
References in periodicals archive ?
After the addition of anti-TNF-[alpha] to M-CSF + RANKL treatment, the observed differences in the erosion profile between the three groups were lost (Figure 2(b)).
Zlotnik, "Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage," Journal of Leukocyte Biology, vol.
IL: interleukin; MMP: matrix metalloproteinase; M-CSF: macrophage colony-stimulating factor.
Osteoclast precursors were treated with macrophage colony-stimulating factor (M-CSF) alone, M-CSF with RANKL, M-CSF with RANKL and exendin-4, and M-CSF with exendin-4 for 5 days, then stained with TRAP solution.
(a) BMMs were incubated in 10% FBS-[alpha]-MEM containing M-CSF (30 ng/ml) and liensinine or nuciferine at various concentrations for 5 days.
Western blot analysis indicated that sanguiin H-6 strongly inhibited the nuclear translocation of NFATc1, phosphorylated-c-Fos, and NF-[kappa]B 6 and 24 h after M-CSF and RANKL treatment, although M-CSF and RANKL markedly activated these transcription factors (Fig.
M-CSF and its receptor are potential therapeutic targets in mechanical stress-induced odontoclastogenesis, and injection of an anti-c-Fms antibody might be useful to prevent mechanical stress-induced root resorption during orthodontic tooth movement.
O'Keeffe, "M-CSF: a novel plasmacytoid and conventional dendritic cell poietin," Blood, vol.
Splenocytes were cultured in methylcellulose-based medium (StemCell Technologies, Vancouver, British Columbia, Canada) supplemented with M-CSF (30 ng/mL) for 12 days.
M-CSF is an important growth factor involved in the development of specific cells which are involved in the immune responses in the lungs.
The fact that osteoblasts secrete two major cytokines, namely, macrophage colony stimulating factor (M-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) led this group to believe that recombinant BMP-2 may play a major role in hematopoiesis, and further, serve as a potential cytokine in stem cell transplantation.